Literature DB >> 1433513

U3 long terminal repeat-mediated induction of intracellular immunity by a murine retrovirus: a novel model of latency for retroviruses.

I Gorska-Flipot1, M Huang, M Cantin, E Rassart, G Massé, P Jolicoeur.   

Abstract

BL/VL3 radiation leukemia virus (RadLV) is a thymotropic, highly leukemogenic murine leukemia virus (MuLV) which is unable to replicate in vitro in mouse fibroblasts. We have previously reported that the U3 long terminal repeat region of its genome is responsible for this block (E. Rassart, Y. Paquette, and P. Jolicoeur, J. Virol. 62:3840-3848, 1988). By using hybrids of permissive and resistant cells infected with BL/VL3 RadLV or fibrotropic MuLV, we found that the resistant phenotype was dominant. Investigation to determine at which step of the virus cycle the block operates revealed that integration, transcription, and translation of the BL/VL3 viral genome occurred at normal levels in nonpermissive cells. The BL/VL3 RadLV Pr65gag proteins made in nonpermissive cells were also myristylated and located at the membrane, and the levels of their cleaved products were similar to those of fibrotropic MuLV. However, processing of BL/VL3 RadLV Pr85env was impaired in nonpermissive cells. Virions were not released into the culture medium of nonpermissive cells, as measured by reverse transcriptase activity and by content in p30 or gp70 protein and as documented by lower levels of budding particles seen by electron microscopy. These results indicate that BL/VL3 RadLV replication is blocked at a late stage of the virus cycle, i.e., at virion assembly. Interestingly, these BL/VL3 RadLV-infected nonpermissive fibroblasts were resistant to superinfection by fibrotropic Moloney MuLV, and this resistance also occurred at a late step of the Moloney virus cycle. Since this block is dominant, it appears that the U3 long terminal repeat region of the BL/VL3 viral genome has the ability to induce a cellular suppressor factor(s), thus bringing intracellular immunity against itself and against other ecotropic MuLVs.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1433513      PMCID: PMC240418     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  51 in total

1.  Expression of human class II major histocompatibility complex antigens using retrovirus vectors.

Authors:  A J Korman; J D Frantz; J L Strominger; R C Mulligan
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

Review 2.  Mutants of murine leukemia viruses and retroviral replication.

Authors:  S P Goff; L I Lobel
Journal:  Biochim Biophys Acta       Date:  1987-07-08

3.  Gene therapy. Intracellular immunization.

Authors:  D Baltimore
Journal:  Nature       Date:  1988-09-29       Impact factor: 49.962

4.  Myristylation site in Pr65gag is essential for virus particle formation by Moloney murine leukemia virus.

Authors:  A Rein; M R McClure; N R Rice; R B Luftig; A M Schultz
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

5.  Revertants of v-fos-transformed fibroblasts have mutations in cellular genes essential for transformation by other oncogenes.

Authors:  H Zarbl; J Latreille; P Jolicoeur
Journal:  Cell       Date:  1987-11-06       Impact factor: 41.582

6.  A proposed nomenclature for the virion proteins of oncogenic RNA viruses.

Authors:  J T August; D P Bolognesi; E Fleissner; R V Gilden; R C Nowinski
Journal:  Virology       Date:  1974-08       Impact factor: 3.616

7.  Analysis of type specific antigenic determinants of two structural polypeptides of mouse RNA C-Type viruses.

Authors:  J R Stephenson; S R Tronick; S A Aaronson
Journal:  Virology       Date:  1974-03       Impact factor: 3.616

8.  Deficiency of 60 to 70S RNA in murine leukemia virus particles assembled in cells treated with actinomycin D.

Authors:  J G Levin; P M Grimley; J M Ramseur; I K Berezesky
Journal:  J Virol       Date:  1974-07       Impact factor: 5.103

9.  Polypeptides of mammalian oncornaviruses. I. Isolation and serological analysis polypeptides from murine and feline C-type viruses.

Authors:  R W Green; D P Bolognesi; W Schäfer; L Pister; G Hunsmann; F De Noronha
Journal:  Virology       Date:  1973-12       Impact factor: 3.616

10.  Proteins of helper-dependent RSV.

Authors:  C M Scheele; H Hanafusa
Journal:  Virology       Date:  1971-08       Impact factor: 3.616

View more
  3 in total

1.  A transcript from the long terminal repeats of a murine retrovirus associated with trans activation of cellular genes.

Authors:  S Y Choi; D V Faller
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

2.  Flamenco, a gene controlling the gypsy retrovirus of Drosophila melanogaster.

Authors:  N Prud'homme; M Gans; M Masson; C Terzian; A Bucheton
Journal:  Genetics       Date:  1995-02       Impact factor: 4.562

3.  Persistent baculovirus infection results from deletion of the apoptotic suppressor gene p35.

Authors:  J C Lee; H H Chen; Y C Chao
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.